129 related articles for article (PubMed ID: 10199751)
1. Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients.
Torpy DJ; Chen CC; Mullen N; Doppman JL; Carrasquillo JA; Chrousos GP; Nieman LK
J Clin Endocrinol Metab; 1999 Apr; 84(4):1186-92. PubMed ID: 10199751
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
[TBL] [Abstract][Full Text] [Related]
3. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
4. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.
Pacak K; Ilias I; Chen CC; Carrasquillo JA; Whatley M; Nieman LK
J Clin Endocrinol Metab; 2004 May; 89(5):2214-21. PubMed ID: 15126544
[TBL] [Abstract][Full Text] [Related]
5. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.
Zemskova MS; Gundabolu B; Sinaii N; Chen CC; Carrasquillo JA; Whatley M; Chowdhury I; Gharib AM; Nieman LK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1207-19. PubMed ID: 20089611
[TBL] [Abstract][Full Text] [Related]
6. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.
Grossrubatscher E; Vignati F; Dalino P; Possa M; Belloni PA; Vanzulli A; Bramerio M; Marocchi A; Rossetti O; Zurleni F; Loli P
J Endocrinol Invest; 2005 Jan; 28(1):72-8. PubMed ID: 15816375
[TBL] [Abstract][Full Text] [Related]
7. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for somatostatin and its analogs in Cushing's syndrome?
de Herder WW; Lamberts SW
Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
[TBL] [Abstract][Full Text] [Related]
9. Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111indium-DTPA labelled octreotide.
Tsagarakis S; Giannakenas C; Vassilakos PJ; Platis O; Belenis I; Kaskarelis J; Rontoyianni D; Thalassinos N
Clin Endocrinol (Oxf); 1995 Dec; 43(6):763-7. PubMed ID: 8736282
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.
Phlipponneau M; Nocaudie M; Epelbaum J; De Keyzer Y; Lalau JD; Marchandise X; Bertagna X
J Clin Endocrinol Metab; 1994 Jan; 78(1):20-4. PubMed ID: 7904613
[TBL] [Abstract][Full Text] [Related]
11. Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide.
Matte J; Roufosse F; Rocmans P; Schoutens A; Jacobovitz D; Mockel J
Postgrad Med J; 1998 Feb; 74(868):108-10. PubMed ID: 9616493
[TBL] [Abstract][Full Text] [Related]
12. The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors.
Özkan ZG; Kuyumcu S; Balköse D; Ozkan B; Aksakal N; Yılmaz E; Sanlı Y; Türkmen C; Aral F; Adalet I
Mol Imaging Radionucl Ther; 2013 Aug; 22(2):49-55. PubMed ID: 24003397
[TBL] [Abstract][Full Text] [Related]
13. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
14. Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors.
Shaverdian N; Pinchot SN; Zarebczan B; Gillis HC; Schiro A; Chen H
Ann Surg Oncol; 2013 Feb; 20(2):640-5. PubMed ID: 22941169
[TBL] [Abstract][Full Text] [Related]
15. [Gammagraphy of somatostatin receptors in an ACTH secreting thymic carcinoid].
Banzo J; Razola P; Prats E; Freile E; Benito JL; García López F; García Tirado J; Abós MD
Rev Esp Med Nucl; 1999; 18(2):99-103. PubMed ID: 10352322
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogs in ectopic corticotropin production.
von Werder K; Muller OA; Stalla GK
Metabolism; 1996 Aug; 45(8 Suppl 1):129-31. PubMed ID: 8769407
[TBL] [Abstract][Full Text] [Related]
17. Localization of ectopic corticotropin-producing carcinoid tumor with use of indium-111 pentetreotide scintigraphy.
Bakalakos EA; Cawley K; O'Dorisio TM; Heck C; Schirmer WJ
Endocr Pract; 1998; 4(6):378-81. PubMed ID: 15251712
[TBL] [Abstract][Full Text] [Related]
18. ⁶⁸Ga-DOTATOC PET-CT in the localization of source of ectopic ACTH in patients with ectopic ACTH-dependent Cushing's syndrome.
Venkitaraman B; Karunanithi S; Kumar A; Bal C; Ammini AC; Kumar R
Clin Imaging; 2014; 38(2):208-11. PubMed ID: 24332975
[TBL] [Abstract][Full Text] [Related]
19. A case of bronchopulmonary carcinoid tumor: the role of octreotide scanning in localization of an ectopic source of ACTH.
Bhatia PD; Fung K; Edmonds M; Driedger AA; Malthaner RA
J Hosp Med; 2006 Sep; 1(5):312-6. PubMed ID: 17219518
[TBL] [Abstract][Full Text] [Related]
20. Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques.
Loli P; Vignati F; Grossrubatscher E; Dalino P; Possa M; Zurleni F; Lomuscio G; Rossetti O; Ravini M; Vanzulli A; Bacchetta C; Galli C; Valente D
J Clin Endocrinol Metab; 2003 Mar; 88(3):1029-35. PubMed ID: 12629081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
